Ignite Creation Date:
2024-05-06 @ 2:35 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04364854
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-06
First Post:
2020-04-23
Brief Title:
Speech Entrainment for Aphasia Recovery
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Study Overview
Official Title:
Speech Entrainment for Aphasia Recovery
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SpARc
Brief Summary:
After a stroke many people experience a language impairment called aphasia One of the most debilitating types of aphasia is non-fluent aphasia Non-fluent aphasia is defined by significantly reduced speech production with the speaker producing only a few words or even less Speech entrainment therapy SET is a treatment that has been shown to increase fluency in people with non-fluent aphasia The study looks to define the best dose of SET that leads to sustained improvements in spontaneous speech production
Participants who are eligible will undergo baseline language testing an MRI and will be randomized into one of 4 treatment groups SET for 3 weeks SET for 45 weeks SET for 6 weeks and no treatment control group
Participants who are eligible will undergo baseline language testing an MRI and will be randomized into one of 4 treatment groups SET for 3 weeks SET for 45 weeks SET for 6 weeks and no treatment control group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U01DC017521-01A1 | NIH | None | httpsreporternihgovquickSearchU01DC017521-01A1 |